Global Fund launches new funding model, says $1.9B available during transition period

"The Global Fund to Fight AIDS, Tuberculosis and Malaria [on Thursday] launched a new funding model that allows it to invest more strategically, achieve greater impact, and engage implementers and partners more effectively," a Global Fund press release reports. Noting "[t]he new funding model replaces the former 'rounds' system of funding, which had one timing window for funding applications," the press release continues, "The new funding model provides countries that implement grants with more flexibility around when they apply for funds, as well as more predictability on the level of funding available, while still encouraging countries to clearly express how much funding they need to effectively treat and prevent HIV/AIDS, [tuberculosis (TB)] and malaria" (2/28).

"The Global Fund forecasts that $1.9 billion will be available in 2013-2014 for the transition period of the new funding model (NFM)," which "will run from March 2013 to September 2014," the Global Fund Observer writes. The newsletter adds, "The Global Fund has identified 57 early and interim applicants which will be allowed to submit applications for funding during the transition period," including countries and regional initiatives (3/1). According to PlusNews, Global Fund Executive Director Mark Dybul said in a statement, "The new funding model gives us a special chance to learn and adapt. During this year, we will monitor various aspects of the new funding model process so that we can adapt in real time. We are a learning institution, and we will gain insight and knowledge as we work together" (2/28).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds artemisinin resistance in African children with severe malaria